Comparison of intravenous immunoglobulin and ganciclovir in treatment of cytomegalovirus pneumonia in newborn infants
CHEN Zhuang-gui,JI Jing-zhi,CHEN Fen-hua,CHEN Yan-feng,BU Jun,SUN Jian-hua
DOI: https://doi.org/10.3760/cma.j.issn.1003-9279.2006.04.036
2006-01-01
Abstract:Objective Human cytomegalovirus(HCMV)is the most common agent causing congenital infection in humans.Although newborns are born infected with human cytomegalovirus,only a few of them show symptoms at birth,of which cytomegalovirus pneumonia is the serious one.This study was to investigate the therapeutic effect and safety of intravenous immunoglobulin in treatment of cytomegalovirus pneumonia in newborns.Methods A retrospective analysis was conducted on 24 newborns with human cytomegalovirus pneumonia who were admitted into the hosipital from Jul.2000 to Mar.2006,which were randomly segregated into two groups with different management.There were 13 cases in the contral group treated with intravenous ganciclovir(5 mg/kg q12h)for 14 days,the management group had 11 cases treated with intravenous immunoglobulin(400 mg/kg,per day)for 10 days.Observation item:①clinical:hospitalization time,the time when the physical sign of lung;②lab item:concention of hemoglobin,white blood cell counted,platelet counted;hepatic function;the copies of HCMV-DNA;③follow up:all the patients were followed up every three months after discharged,the symptoms and the physical signs of lung as well as the copies of HCMV-DNA were determined.The two groups of patients were similar in terms of age,gestational age,body weight,sex,and underlying disease.Results The effective power of the managment group treated with intravenous immunoglobulin was 81.8% versus 53.8% in the controll group which was treated with intravenous ganciclovir,and there was no significant difference between the two groups(χ2=2.329,P>0.05);the copies of HCMV-DNA in two groups were not significantly different(t=-2.512,P>0.05);The mean duration of hospitalization in the intravenous immunoglobulin group was(23±5.6)day and(28.6±7)day in the controll group treated with ganciclovir,and there was significant difference between the two group in the duration of hospitalization(t=-2.164,P<0.05).The mean time of physical sign of lung began to vanish in the intravenous immunoglobulin group was(7.45±1.37)day and(9.58±2.61)day in the controll group(t=-2.415,P<0.05).Two cases in the controll group greated with intravenous ganciclovir had to stop the medication because of WBC<0.5×109/L,plt<25×109/L,and an infant died of respiratory failure during the treatment in this group.Conclusion The effectiveness of intravenous immune globulin in treatment of cytomegalovirus pneumonia was similar to that of intravenous ganciclovir,however,the safety and therapeutic effect of intravenous immune globulin were better than those of intravenous ganciclovir in.